Follow Us Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Food and Drug Act Health Care Law Products Liability

Genetic Labeling: Legal Uncertainty for Pharma Product Liability

The FDA’s recent approval of 23andMe’s direct-to-consumer genetic test to identify genes associated with 10 common diseases and disorders could result in a widespread expansion of patients armed with individualized health information. This expansion of genetic information in the hands of consumers potentially impacts regulatory and litigation issues for pharmaceutical companies.


Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Customization of products and services is becoming increasingly popular. Today, we can individualize anything from a salad to a car. In fact, surveys from Bain & Co. and Deloitte have confirmed that over one-third of consumers are interested in personalized products.

To continue reading,
become a free ALM digital reader

Benefits include:

*May exclude premium content

Read These Next